Articles

Startup company Vivlion has signed a non-exclusive license agreement with ERS Genomics granting access to CRISPR/Cas9 patent portfolio.

Vivlion Signs Worldwide License Agreement for CRISPR/Cas9 Patent Portfolio

New data from CGT Catapult has demonstrated progression by the industry toward commercialization of therapies and an increase in GMP manufacturing space.

CGT Catapult Report Shows Industry Progress to Commercialization of Therapies

A longer-than-expected scale up of raw materials forces Pfizer to cut 2020 vaccine production in half.

Raw Material Delays Cut Pfizer Vaccine Production

Lonza has formed a long-term, strategic collaboration with a global biopharma company for bioconjugation. 

Lonza Announces Long-Term Collaboration with Global Biopharma Company

Honeywell’s project team has remotely and efficiently migrated Richter Gedeon’s process control system with limited onsite staffing and resources.

Honeywell Completes Remote Control System Migration for Hungarian Pharma Manufacturer

A novel PTA technology captures more than 95% of the genomes of single cells, providing more uniform, accurate, and reproducible single-cell analysis data.

BioSkryb Discusses First Data Demonstrating Improved Accuracy in Single Cell Analyses

The collaboration addresses the need for risk mitigation plans in cell therapies.

Cytiva and 4Tune Engineering Collaborate on Cell Therapy Quality Risk Management

Janssen announces rolling submissions for its COVID-19 vaccine with Health Canada and EMA.

J&J Initiates COVID-19 Vaccine Approvals in Canada and Europe

The gene therapy increases the ability of retina cells to make a soluble form of CD59, a protein that shields the retina from damage, to prevent additional damage and to preserve vision. 

Janssen Pharmaceuticals Announces Acquisition of Vision Care Gene Therapy

Set to be operational by the first quarter of 2022, the 140,000-ft2 facility will feature up to six 2000-L, single-use bioreactor systems along with additional harvest and purification equipment to produce up to 100 commercial batches annually. 

News